Newer Drugs for Rheumatoid Arthritis All Have Similar Risks — Maybe It’s Time to Go Natural?

Verve Times
15 March 2022
https://vervetimes.com/newer-drugs-for-rheumatoid-arthritis-all-have-similar-risks-maybe-its-time-to-go-natural/

Dr Sajad Zalzala, LDN Radio Show February 2022 (LDN, low dose naltrexone)

Repurposing low-dose naltrexone (LDN) for the prevention and treatment of immunothrombosis in COVID-19 (Abstract)

Eur Heart J Cardiovasc Pharmacother
18 February 2022
https://pubmed.ncbi.nlm.nih.gov/35179184/

Low-Dose Naltrexone Presents New Options for Patients with Inflammatory, Autoimmune Diseases

Pharmacy Times
20 February 2022
https://www.pharmacytimes.com/view/low-dose-naltrexone-presents-new-options-for-patients-with-inflammatory-autoimmune-diseases